The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - AIMM Therapeutics; Kite, a Gilead company; Neon Therapeutics
Honoraria - AIMM Therapeutics; Neon Therapeutics
Research Funding - Bristol-Myers Squibb; Merck
Spatial proximity of CD8 T cells to tumor cells as an independent biomarker for response to anti-PD-1 therapy.
 
Maarten Slagter
No Relationships to Disclose
 
Elisa A. Rozeman
No Relationships to Disclose
 
Huiwen Ding
No Relationships to Disclose
 
Judith M. Versluis
No Relationships to Disclose
 
Mesele Valenti
Employment - Genmab
 
Dennis Peters
No Relationships to Disclose
 
Annegien Broeks
No Relationships to Disclose
 
Charlotte van Rooijen
No Relationships to Disclose
 
Hugo Horlings
No Relationships to Disclose
 
John B. A. G. Haanen
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Neon Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD (Inst)
 
Erik Hooijberg
No Relationships to Disclose
 
Lodewyk F. A. Wessels
No Relationships to Disclose
 
Christian U. Blank
Stock and Other Ownership Interests - Forty Seven; Neon Therapeutics; Uniti Cars
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); GenMab (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche/Genentech (Inst); Third Rock Ventures
Research Funding - Bristol-Myers Squibb (Inst); NanoString Technologies (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Ton N. Schumacher
No Relationships to Disclose